_id
691856e63c536f8df23179e9
Ticker
0IGA.LSE
Name
Emergent Biosolutions Inc.
Exchange
LSE
Address
300 Professional Drive, Gaithersburg, MD, United States, 20879
Country
UK
Sector
Industry
Currency
USD
Website
https://www.emergentbiosolutions.com
Description
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; Botulism Antitoxin Heptavalent for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Trobigard, an atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Last Close
13.29
Volume
2550
Current Price
13.85
Change
0.0908
Last Updated
2026-01-08T13:59:56.881Z
Image
https://logo.clearbit.com/www.emergentbiosolutions.com
Ipo Date
-
Market Cap
61159110400
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
231100000
Cost Of Revenue
91700000
Gross Profit
139400000
Operating Expenses
62900000
Operating Income
76500000
Interest Expense
15200000
Pretax Income
57600000
Net Income
51200000
Eps
0.9061946902654867
Dividends Per Share
-
Shares Outstanding
50945100
Income Tax Expense
6400000
EBITDA
96200000
Operating Margin
33.10255300735612
Total Other Income Expense Net
-18900000
Cash
245500000
Short Term Investments
-
Receivables
149500000
Inventories
356300000
Total Current Assets
786900000
Property Plant Equipment
209800000
Total Assets
1461000000
Payables
57400000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
878500000
Equity
582500000
Bs_currency_symbol
-
Depreciation
23400000
Change In Working Capital
-81400000
Cash From Operations
-2300000
Capital Expenditures
3400000
Cash From Investing
-3400000
Cash From Financing
-15900000
Net Change In Cash
-21800000
Cf_currency_symbol
-
PE
0.0467
PB
1.3433905579399141
ROE
8.78969957081545
ROA
3.5044490075290895
FCF
-5700000
Fcf Percent
-0.024664647338814367
Piotroski FScore
2
Health Score
49
Deep Value Investing Score
5.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
5.5
Value Investing Score
8.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
231100000
Quarters > 0 > income Statement > cost Of Revenue
91700000
Quarters > 0 > income Statement > gross Profit
139400000
Quarters > 0 > income Statement > operating Expenses
62900000
Quarters > 0 > income Statement > operating Income
76500000
Quarters > 0 > income Statement > interest Expense
15200000
Quarters > 0 > income Statement > pretax Income
57600000
Quarters > 0 > income Statement > net Income
51200000
Quarters > 0 > income Statement > eps
0.9061946902654867
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
56500000
Quarters > 0 > income Statement > income Tax Expense
6400000
Quarters > 0 > income Statement > EBITDA
96200000
Quarters > 0 > income Statement > operating Margin
33.10255300735612
Quarters > 0 > income Statement > total Other Income Expense Net
-18900000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
245500000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
149500000
Quarters > 0 > balance Sheet > inventories
356300000
Quarters > 0 > balance Sheet > total Current Assets
786900000
Quarters > 0 > balance Sheet > property Plant Equipment
209800000
Quarters > 0 > balance Sheet > total Assets
1461000000
Quarters > 0 > balance Sheet > payables
57400000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
878500000
Quarters > 0 > balance Sheet > equity
582500000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
51200000
Quarters > 0 > cash Flow > depreciation
23400000
Quarters > 0 > cash Flow > change In Working Capital
-81400000
Quarters > 0 > cash Flow > cash From Operations
-2300000
Quarters > 0 > cash Flow > capital Expenditures
3400000
Quarters > 0 > cash Flow > cash From Investing
-3400000
Quarters > 0 > cash Flow > cash From Financing
-15900000
Quarters > 0 > cash Flow > net Change In Cash
-21800000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.9061946902654867
Quarters > 0 > ratios > PB
1.3433905579399141
Quarters > 0 > ratios > ROE
8.78969957081545
Quarters > 0 > ratios > ROA
3.5044490075290895
Quarters > 0 > ratios > FCF
-5700000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.024664647338814367
Quarters > 0 > health Score
49
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
140900000
Quarters > 1 > income Statement > cost Of Revenue
80200000
Quarters > 1 > income Statement > gross Profit
60700000
Quarters > 1 > income Statement > operating Expenses
59100000
Quarters > 1 > income Statement > operating Income
1600000
Quarters > 1 > income Statement > interest Expense
14700000
Quarters > 1 > income Statement > pretax Income
-16800000
Quarters > 1 > income Statement > net Income
-12000000
Quarters > 1 > income Statement > eps
-0.22140221402214022
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
54200000
Quarters > 1 > income Statement > income Tax Expense
-4800000
Quarters > 1 > income Statement > EBITDA
23500000
Quarters > 1 > income Statement > operating Margin
1.1355571327182399
Quarters > 1 > income Statement > total Other Income Expense Net
-18400000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
271000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
79800000
Quarters > 1 > balance Sheet > inventories
338600000
Quarters > 1 > balance Sheet > total Current Assets
719500000
Quarters > 1 > balance Sheet > property Plant Equipment
223800000
Quarters > 1 > balance Sheet > total Assets
1417100000
Quarters > 1 > balance Sheet > payables
63700000
Quarters > 1 > balance Sheet > short Term Debt
1800000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
880900000
Quarters > 1 > balance Sheet > equity
536200000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-12000000
Quarters > 1 > cash Flow > depreciation
23500000
Quarters > 1 > cash Flow > change In Working Capital
95700000
Quarters > 1 > cash Flow > cash From Operations
106400000
Quarters > 1 > cash Flow > capital Expenditures
2900000
Quarters > 1 > cash Flow > cash From Investing
17200000
Quarters > 1 > cash Flow > cash From Financing
-6400000
Quarters > 1 > cash Flow > net Change In Cash
118200000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.22140221402214022
Quarters > 1 > ratios > PB
1.3999813502424467
Quarters > 1 > ratios > ROE
-2.237970906378217
Quarters > 1 > ratios > ROA
-0.8467998024133795
Quarters > 1 > ratios > FCF
103500000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.7345635202271115
Quarters > 1 > health Score
44
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
222200000
Quarters > 2 > income Statement > cost Of Revenue
102800000
Quarters > 2 > income Statement > gross Profit
119400000
Quarters > 2 > income Statement > operating Expenses
69500000
Quarters > 2 > income Statement > operating Income
49900000
Quarters > 2 > income Statement > interest Expense
14700000
Quarters > 2 > income Statement > pretax Income
92700000
Quarters > 2 > income Statement > net Income
68000000
Quarters > 2 > income Statement > eps
1.1867364746945899
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
57300000
Quarters > 2 > income Statement > income Tax Expense
24700000
Quarters > 2 > income Statement > EBITDA
75200000
Quarters > 2 > income Statement > operating Margin
22.45724572457246
Quarters > 2 > income Statement > total Other Income Expense Net
42800000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
149100000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
203700000
Quarters > 2 > balance Sheet > inventories
314000000
Quarters > 2 > balance Sheet > total Current Assets
706800000
Quarters > 2 > balance Sheet > property Plant Equipment
221000000
Quarters > 2 > balance Sheet > total Assets
1426100000
Quarters > 2 > balance Sheet > payables
58100000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
873400000
Quarters > 2 > balance Sheet > equity
552700000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
68000000
Quarters > 2 > cash Flow > depreciation
25400000
Quarters > 2 > cash Flow > change In Working Capital
-118700000
Quarters > 2 > cash Flow > cash From Operations
-11200000
Quarters > 2 > cash Flow > capital Expenditures
3600000
Quarters > 2 > cash Flow > cash From Investing
59500000
Quarters > 2 > cash Flow > cash From Financing
-400000
Quarters > 2 > cash Flow > net Change In Cash
47200000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
1.1867364746945899
Quarters > 2 > ratios > PB
1.4358693685543693
Quarters > 2 > ratios > ROE
12.303238646643749
Quarters > 2 > ratios > ROA
4.768249070892644
Quarters > 2 > ratios > FCF
-14800000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.0666066606660666
Quarters > 2 > health Score
53
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
194700000
Quarters > 3 > income Statement > cost Of Revenue
58200000
Quarters > 3 > income Statement > gross Profit
136500000
Quarters > 3 > income Statement > operating Expenses
146000000
Quarters > 3 > income Statement > operating Income
-9500000
Quarters > 3 > income Statement > interest Expense
14800000
Quarters > 3 > income Statement > pretax Income
-27600000
Quarters > 3 > income Statement > net Income
-31300000
Quarters > 3 > income Statement > eps
-0.577490774907749
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
54200000
Quarters > 3 > income Statement > income Tax Expense
3700000
Quarters > 3 > income Statement > EBITDA
21000000
Quarters > 3 > income Statement > operating Margin
-4.879301489470981
Quarters > 3 > income Statement > total Other Income Expense Net
-18100000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
105600000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
154500000
Quarters > 3 > balance Sheet > inventories
311700000
Quarters > 3 > balance Sheet > total Current Assets
598700000
Quarters > 3 > balance Sheet > property Plant Equipment
282300000
Quarters > 3 > balance Sheet > total Assets
1396900000
Quarters > 3 > balance Sheet > payables
60900000
Quarters > 3 > balance Sheet > short Term Debt
2700000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
914100000
Quarters > 3 > balance Sheet > equity
482800000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-31300000
Quarters > 3 > cash Flow > depreciation
26000000
Quarters > 3 > cash Flow > change In Working Capital
-85300000
Quarters > 3 > cash Flow > cash From Operations
-79900000
Quarters > 3 > cash Flow > capital Expenditures
1700000
Quarters > 3 > cash Flow > cash From Investing
28600000
Quarters > 3 > cash Flow > cash From Financing
500000
Quarters > 3 > cash Flow > net Change In Cash
-50800000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.577490774907749
Quarters > 3 > ratios > PB
1.5548260149130073
Quarters > 3 > ratios > ROE
-6.483015741507871
Quarters > 3 > ratios > ROA
-2.2406757820889114
Quarters > 3 > ratios > FCF
-81600000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-0.41910631741140214
Quarters > 3 > health Score
24
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1043599999
Annuals > 0 > income Statement > cost Of Revenue
668200000
Annuals > 0 > income Statement > gross Profit
375400000
Annuals > 0 > income Statement > operating Expenses
484099999
Annuals > 0 > income Statement > operating Income
-108700000
Annuals > 0 > income Statement > interest Expense
71000000
Annuals > 0 > income Statement > pretax Income
-142900000
Annuals > 0 > income Statement > net Income
-190600000
Annuals > 0 > income Statement > eps
-3.5962264150943395
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
53000000
Annuals > 0 > income Statement > income Tax Expense
47700000
Annuals > 0 > income Statement > EBITDA
53400000
Annuals > 0 > income Statement > operating Margin
-10.415868158696693
Annuals > 0 > income Statement > total Other Income Expense Net
-34200000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
99500000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
154500000
Annuals > 0 > balance Sheet > inventories
311700000
Annuals > 0 > balance Sheet > total Current Assets
598700000
Annuals > 0 > balance Sheet > property Plant Equipment
270600000
Annuals > 0 > balance Sheet > total Assets
1389700000
Annuals > 0 > balance Sheet > payables
60900000
Annuals > 0 > balance Sheet > short Term Debt
2700000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
906900000
Annuals > 0 > balance Sheet > equity
482800000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-190600000
Annuals > 0 > cash Flow > depreciation
108800000
Annuals > 0 > cash Flow > change In Working Capital
88700000
Annuals > 0 > cash Flow > cash From Operations
58700000
Annuals > 0 > cash Flow > capital Expenditures
22900000
Annuals > 0 > cash Flow > cash From Investing
125200000
Annuals > 0 > cash Flow > cash From Financing
-190000000
Annuals > 0 > cash Flow > net Change In Cash
-6100000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-3.5962264150943395
Annuals > 0 > ratios > PB
1.5204018227009115
Annuals > 0 > ratios > ROE
-39.47804473902237
Annuals > 0 > ratios > ROA
-13.715190328847953
Annuals > 0 > ratios > FCF
35800000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.034304331194235656
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1049300000
Annuals > 1 > income Statement > cost Of Revenue
689300000
Annuals > 1 > income Statement > gross Profit
360000000
Annuals > 1 > income Statement > operating Expenses
1086400000
Annuals > 1 > income Statement > operating Income
-726400000
Annuals > 1 > income Statement > interest Expense
87900000
Annuals > 1 > income Statement > pretax Income
-731200000
Annuals > 1 > income Statement > net Income
-760500000
Annuals > 1 > income Statement > eps
-14.853515625
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
51200000
Annuals > 1 > income Statement > income Tax Expense
29300000
Annuals > 1 > income Statement > EBITDA
-47000000
Annuals > 1 > income Statement > operating Margin
-69.2271037834747
Annuals > 1 > income Statement > total Other Income Expense Net
-4800000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
111700000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
191000000
Annuals > 1 > balance Sheet > inventories
328900000
Annuals > 1 > balance Sheet > total Current Assets
679500000
Annuals > 1 > balance Sheet > property Plant Equipment
399000000
Annuals > 1 > balance Sheet > total Assets
1823200000
Annuals > 1 > balance Sheet > payables
112200000
Annuals > 1 > balance Sheet > short Term Debt
413700000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1173900000
Annuals > 1 > balance Sheet > equity
649300000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-760500000
Annuals > 1 > cash Flow > depreciation
125100000
Annuals > 1 > cash Flow > change In Working Capital
-70300000
Annuals > 1 > cash Flow > cash From Operations
-206300000
Annuals > 1 > cash Flow > capital Expenditures
51600000
Annuals > 1 > cash Flow > cash From Investing
212300000
Annuals > 1 > cash Flow > cash From Financing
-535700000
Annuals > 1 > cash Flow > net Change In Cash
-530900000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-14.853515625
Annuals > 1 > ratios > PB
1.0921299861389189
Annuals > 1 > ratios > ROE
-117.12613583859542
Annuals > 1 > ratios > ROA
-41.71237384817903
Annuals > 1 > ratios > FCF
-257900000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.24578290288763938
Annuals > 1 > health Score
24
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1117500000
Annuals > 2 > income Statement > cost Of Revenue
644500000
Annuals > 2 > income Statement > gross Profit
473000000
Annuals > 2 > income Statement > operating Expenses
643000000
Annuals > 2 > income Statement > operating Income
-170000000
Annuals > 2 > income Statement > interest Expense
37300000
Annuals > 2 > income Statement > pretax Income
-219000000
Annuals > 2 > income Statement > net Income
-211600000
Annuals > 2 > income Statement > eps
-4.2235528942115765
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
50100000
Annuals > 2 > income Statement > income Tax Expense
-7400000
Annuals > 2 > income Statement > EBITDA
15700000
Annuals > 2 > income Statement > operating Margin
-15.212527964205815
Annuals > 2 > income Statement > total Other Income Expense Net
-49000000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
642600000
Annuals > 2 > balance Sheet > short Term Investments
8500000
Annuals > 2 > balance Sheet > receivables
159200000
Annuals > 2 > balance Sheet > inventories
350700000
Annuals > 2 > balance Sheet > total Current Assets
1210400000
Annuals > 2 > balance Sheet > property Plant Equipment
837000000
Annuals > 2 > balance Sheet > total Assets
3166300000
Annuals > 2 > balance Sheet > payables
103500000
Annuals > 2 > balance Sheet > short Term Debt
963100000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1778600000
Annuals > 2 > balance Sheet > equity
1387700000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-211600000
Annuals > 2 > cash Flow > depreciation
143300000
Annuals > 2 > cash Flow > change In Working Capital
-2100000
Annuals > 2 > cash Flow > cash From Operations
-34100000
Annuals > 2 > cash Flow > capital Expenditures
115800000
Annuals > 2 > cash Flow > cash From Investing
-381300000
Annuals > 2 > cash Flow > cash From Financing
481200000
Annuals > 2 > cash Flow > net Change In Cash
66300000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-4.2235528942115765
Annuals > 2 > ratios > PB
0.5000252215896808
Annuals > 2 > ratios > ROE
-15.248252504143547
Annuals > 2 > ratios > ROA
-6.68287907020813
Annuals > 2 > ratios > FCF
-149900000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.1341387024608501
Annuals > 2 > health Score
24
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1773600000
Annuals > 3 > income Statement > cost Of Revenue
980400000
Annuals > 3 > income Statement > gross Profit
793200000
Annuals > 3 > income Statement > operating Expenses
451800000
Annuals > 3 > income Statement > operating Income
341400000
Annuals > 3 > income Statement > interest Expense
34500000
Annuals > 3 > income Statement > pretax Income
303200000
Annuals > 3 > income Statement > net Income
219500000
Annuals > 3 > income Statement > eps
4.057301293900185
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
54100000
Annuals > 3 > income Statement > income Tax Expense
83700000
Annuals > 3 > income Statement > EBITDA
504200000
Annuals > 3 > income Statement > operating Margin
19.248985115020297
Annuals > 3 > income Statement > total Other Income Expense Net
-38200000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
576300000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
278900000
Annuals > 3 > balance Sheet > inventories
344500000
Annuals > 3 > balance Sheet > total Current Assets
1269900000
Annuals > 3 > balance Sheet > property Plant Equipment
828400000
Annuals > 3 > balance Sheet > total Assets
2957700000
Annuals > 3 > balance Sheet > payables
128900000
Annuals > 3 > balance Sheet > short Term Debt
37400000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1346200000
Annuals > 3 > balance Sheet > equity
1611500000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
230900000
Annuals > 3 > cash Flow > depreciation
123800000
Annuals > 3 > cash Flow > change In Working Capital
-156400000
Annuals > 3 > cash Flow > cash From Operations
321100000
Annuals > 3 > cash Flow > capital Expenditures
225000000
Annuals > 3 > cash Flow > cash From Investing
-225000000
Annuals > 3 > cash Flow > cash From Financing
-141000000
Annuals > 3 > cash Flow > net Change In Cash
-45200000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
4.057301293900185
Annuals > 3 > ratios > PB
0.46496121625814457
Annuals > 3 > ratios > ROE
13.62085013962147
Annuals > 3 > ratios > ROA
7.421307096730567
Annuals > 3 > ratios > FCF
96100000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.05418358141632837
Annuals > 3 > health Score
67
Valuation > metrics > PE
0.0467
Valuation > metrics > PB
1.3433905579399141
Valuation > final Score
100
Valuation > verdict
49.8% Undervalued
Profitability > metrics > ROE
8.78969957081545
Profitability > metrics > ROA
6.506544668954124
Profitability > metrics > Net Margin
0.22154911293812202
Profitability > final Score
67
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
1.5081545064377682
Risk > metrics > Interest Coverage
5.032894736842105
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
13.709059233449477
Liquidity > metrics > Quick Ratio
7.501742160278746
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
100
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
83
Prev Profitabilities > 2
0
Prev Risks > 0
30
Prev Risks > 1
44
Prev Risks > 2
27
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:53:59.632Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-04
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
0.11
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-29
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.9062
Earnings History > 1 > eps Estimate
0.11
Earnings History > 1 > eps Difference
0.7962
Earnings History > 1 > surprise Percent
723.8182
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-06
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.2214
Earnings History > 2 > eps Estimate
-0.49
Earnings History > 2 > eps Difference
0.2686
Earnings History > 2 > surprise Percent
54.8163
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-04-29
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
1.1867
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-04
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.5775
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-06
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
2.0647
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-06
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-5.3821
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-01
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
0.1724
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-06
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.9538
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-08
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-5.0849
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-08
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-5.1538
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-09
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-3.6454
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-27
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-1.7635
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-08
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-1.517
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-01
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-1.128
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-04-28
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.073
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-24
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
3.4991
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-04
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-0.6089
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-07-29
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
0.0852
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-04-29
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
1.2789
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2020-12-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
3.4207
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
0.7274
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
1.7327
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-0.2404
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2019-12-31
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
0.8916
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-09-30
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
0.826
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-06-30
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-0.1845
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-03-31
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
-0.5078
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2018-12-31
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
-0.0668
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-09-30
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
0.4068
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-06-30
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
0.9801
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-03-31
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
-0.099
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; Botulism Antitoxin Heptavalent for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Trobigard, an atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABinghatti’s $500m sukuk debuts on London Stock Exchange TradeArabia
Read more →(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Emergent Biosolutions Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0.11
Date
2025-09-30
EPS Actual
0.9062
EPS Estimate
0.11
EPS Difference
0.7962
Surprise Percent
723.8182%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.